AN EPSTEIN-BARR VIRUS IMMEDIATE-EARLY GENE-PRODUCT TRANS-ACTIVATES GENE-EXPRESSION FROM THE HUMAN IMMUNODEFICIENCY VIRUS LONG TERMINAL REPEAT

被引：153
作者：
KENNEY, S
KAMINE, J
MARKOVITZ, D
FENRICK, R
PAGANO, J
机构：
来源：
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA | 1988年 / 85卷 / 05期
关键词：
D O I：
10.1073/pnas.85.5.1652
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页码：1652 / 1656
页数：5
相关论文
共 37 条
[1]   DNA-SEQUENCE AND EXPRESSION OF THE B95-8 EPSTEIN-BARR VIRUS GENOME [J].
BAER, R ;
BANKIER, AT ;
BIGGIN, MD ;
DEININGER, PL ;
FARRELL, PJ ;
GIBSON, TJ ;
HATFULL, G ;
HUDSON, GS ;
SATCHWELL, SC ;
SEGUIN, C ;
TUFFNELL, PS ;
BARRELL, BG .
NATURE, 1984, 310 (5974) :207-211
[2]   GENOMIC HETEROGENEITY OF AIDS RETROVIRAL ISOLATES FROM NORTH-AMERICA AND ZAIRE [J].
BENN, S ;
RUTLEDGE, R ;
FOLKS, T ;
GOLD, J ;
BAKER, L ;
MCCORMICK, J ;
FEORINO, P ;
PIOT, P ;
QUINN, T ;
MARTIN, M .
SCIENCE, 1985, 230 (4728) :949-951
[3]   SIZING AND MAPPING OF EARLY ADENOVIRUS MESSENGER-RNAS BY GEL-ELECTROPHORESIS OF S1 ENDONUCLEASE-DIGESTED HYBRIDS [J].
BERK, AJ ;
SHARP, PA .
CELL, 1977, 12 (03) :721-732
[4]  
CASAREALE D, 1985, AIDS RES, V1, P253
[5]   BOTH EPSTEIN-BARR-VIRUS (EBV)-ENCODED TRANS-ACTING FACTORS, EB1 AND EB2, ARE REQUIRED TO ACTIVATE TRANSCRIPTION FROM AN EBV EARLY PROMOTER [J].
CHEVALLIERGRECO, A ;
MANET, E ;
CHAVRIER, P ;
MOSNIER, C ;
DAILLIE, J ;
SERGEANT, A .
EMBO JOURNAL, 1986, 5 (12) :3243-3249
[6]   TRANSACTIVATION OF HUMAN-IMMUNODEFICIENCY-VIRUS OCCURS VIA A BIMODAL MECHANISM [J].
CULLEN, BR .
CELL, 1986, 46 (07) :973-982
[7]   IMMEDIATE-EARLY GENE REGION OF HUMAN CYTOMEGALOVIRUS TRANS-ACTIVATES THE PROMOTER OF HUMAN-IMMUNODEFICIENCY-VIRUS [J].
DAVIS, MG ;
KENNEY, SC ;
KAMINE, J ;
PAGANO, JS ;
HUANG, ES .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (23) :8642-8646
[8]   VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITTS LYMPHOMA [J].
EPSTEIN, MA ;
ACHONG, BG ;
BARR, YM .
LANCET, 1964, 1 (733) :702-+
[9]   ACQUIRED IMMUNODEFICIENCY SYNDROME - EPIDEMIOLOGIC, CLINICAL, IMMUNOLOGICAL, AND THERAPEUTIC CONSIDERATIONS [J].
FAUCI, AS ;
MACHER, AM ;
LONGO, DL ;
LANE, HC ;
ROOK, AH ;
MASUR, H ;
GELMANN, EP .
ANNALS OF INTERNAL MEDICINE, 1984, 100 (01) :92-106
[10]  
Favaloro J, 1980, Methods Enzymol, V65, P718
1234